Safeplus International Holdings Limited (BIPH)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $357,540
Last updated: Nov 17, 2026 at 11:04 AM ET
Safeplus International Holdings Limited (BIPH) Financials: Revenue, Profit and Cash Flow
Safeplus International Holdings reported revenue of $23.10B for the fiscal year ended Feb 28, 2026, up 9.8% from the year before. That year, net income was $449.00M with a net margin of 1.9%, operating cash flow was $5.97B and free cash flow was $268.00M. The quarter ended Aug 31, 2026 had revenue of $6.56B and net income of $69.00M.
Revenue and Margins
The operating margin was 25.1% in the fiscal year ended Feb 2026. Over the 9 years to Feb 2026, revenue grew from $2.12B, a compound annual rate of 30.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Feb 2026 | $23.10B | +9.8% | 26.9% | 25.1% | 1.9% |
| Feb 2025 | $21.04B | +17.3% | 25.5% | 23.6% | 1.7% |
| Feb 2024 | $17.93B | +24.3% | 24.9% | 22.6% | 2.0% |
| Feb 2023 | $14.43B | +25.0% | 27.2% | 24.1% | 2.4% |
| Feb 2022 | $11.54B | +29.8% | 28.5% | 25.0% | 6.6% |
| Feb 2021 | $8.88B | +34.7% | 26.3% | 22.8% | 3.6% |
| Feb 2020 | $6.60B | +41.8% | 30.1% | 25.9% | 3.2% |
| Feb 2019 | $4.65B | +31.6% | 52.5% | 30.5% | 4.1% |
| Feb 2018 | $3.54B | +67.1% | 57.3% | 16.2% | 3.5% |
| Feb 2017 | $2.12B | N/A | 49.7% | 20.8% | 17.4% |
Income Statement
In the fiscal year ended Feb 2026, net income rose 27.9% from the year before. In the quarter ended Aug 2026, net income fell 67.1% from the same quarter a year earlier.
Annual
| Line item | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.10B | $21.04B | $17.93B | $14.43B | $11.54B | $8.88B | $6.60B | $4.65B | $3.54B | $2.12B |
| Cost of revenue | $16.88B | $15.68B | $13.47B | $10.51B | $8.25B | $6.55B | $4.61B | $2.21B | $1.51B | $1.06B |
| Gross profit | $6.22B | $5.36B | $4.46B | $3.92B | $3.29B | $2.34B | $1.99B | $2.44B | $2.03B | $1.05B |
| Operating income | $5.80B | $4.96B | $4.05B | $3.48B | $2.88B | $2.02B | $1.71B | $1.42B | $574.00M | $439.00M |
| Net income | $449.00M | $351.00M | $367.00M | $341.00M | $766.00M | $324.00M | $211.00M | $192.00M | $124.00M | $369.00M |
| EBITDA | $11.01B | $8.64B | $7.02B | $5.69B | $6.61B | $3.94B | $2.96B | $2.54B | $1.84B | $1.13B |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.56B | $6.48B | $6.30B | $6.30B | $5.97B | $5.43B | $5.39B | $5.27B | $5.14B | $5.19B | $4.97B | $4.49B |
| Gross profit | $1.67B | $1.59B | $1.70B | $1.80B | $1.56B | $1.43B | $1.43B | $1.37B | $1.26B | $1.27B | $1.39B | $1.10B |
| Operating income | $1.56B | $1.48B | $1.59B | $1.69B | $1.45B | $1.33B | $1.33B | $1.26B | $1.17B | $1.18B | $1.29B | $1.00B |
| Net income | $69.00M | $62.00M | -$86.00M | $219.00M | $210.00M | $74.00M | $26.00M | -$73.00M | $35.00M | $131.00M | -$68.00M | $89.00M |
Balance Sheet
As of Feb 2026, short-term debt of $7.36B exceeded cash and equivalents by $5.30B.
Annual
| Line item | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $128.15B | $104.59B | $100.78B | $72.97B | $73.96B | $61.33B | $56.31B | $36.58B | $29.48B | $21.27B |
| Current assets | $11.98B | $9.61B | $7.98B | $6.69B | $4.90B | $3.71B | $5.84B | $2.28B | $1.51B | $1.63B |
| Cash and equivalents | $2.06B | $1.98B | $1.64B | $1.14B | $1.25B | $742.00M | $699.00M | $444.00M | $341.00M | $702.00M |
| Total liabilities | $92.61B | $74.74B | $66.77B | $47.41B | $47.57B | $39.66B | $34.13B | $21.91B | $16.00B | $11.63B |
| Short-term debt | $7.36B | $4.41B | $6.48B | $3.56B | $3.55B | $1.89B | $1.58B | $985.00M | $463.00M | $574.00M |
| Shareholder equity | $5.62B | $5.62B | $6.24B | $6.29B | $6.84B | $5.36B | $5.98B | $5.45B | $5.56B | $4.99B |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $120.64B | $121.95B | $124.51B | $128.15B | $124.30B | $108.69B | $103.66B | $104.59B | $105.24B | $100.89B | $103.26B | $100.78B |
| Total liabilities | $88.39B | $89.42B | $90.28B | $92.61B | $89.83B | $79.04B | $73.88B | $74.74B | $75.74B | $70.78B | $70.64B | $66.77B |
| Cash and equivalents | $2.67B | $3.08B | $2.46B | $3.20B | $2.61B | $2.34B | $1.46B | $2.07B | $1.60B | $1.33B | $1.58B | $1.64B |
| Shareholder equity | $5.25B | $5.14B | $5.34B | $5.62B | $5.33B | $5.27B | $5.50B | $5.62B | $5.56B | $5.82B | $6.08B | $6.24B |
Cash Flow
In the fiscal year ended Feb 2026, free cash flow was 4.5% of operating cash flow. Dividends came to 649.3% of it.
Annual
| Line item | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.97B | $4.65B | $4.08B | $3.13B | $2.77B | $2.53B | $2.14B | $1.36B | $1.48B | $753.00M |
| Capital expenditures | $5.70B | $4.97B | $2.49B | $2.77B | $2.07B | $1.47B | $1.18B | $839.00M | $714.00M | $690.00M |
| Free cash flow | $268.00M | -$322.00M | $1.59B | $356.00M | $705.00M | $1.06B | $961.00M | $523.00M | $767.00M | $63.00M |
| Dividends paid | $1.74B | $1.64B | $1.52B | $1.42B | $1.26B | $1.13B | $1.03B | $919.00M | $794.00M | $628.00M |
| Investing cash flow | -$12.66B | -$6.90B | -$12.99B | -$3.37B | -$1.17B | -$4.61B | -$11.37B | -$5.56B | -$5.72B | -$1.06B |
| Financing cash flow | $7.82B | $2.61B | $9.42B | $56.00M | -$995.00M | $2.13B | $9.54B | $4.42B | $3.81B | $899.00M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.54B | $1.49B | $893.00M | $2.04B | $1.87B | $1.19B | $868.00M | $1.56B | $1.19B | $1.06B | $841.00M | $1.49B |
| Capital expenditures | $1.27B | $1.22B | $2.03B | $2.03B | $1.91B | $1.02B | $870.00M | $3.09B | $1.16B | $991.00M | $1.57B | $796.00M |
| Free cash flow | $270.00M | $269.00M | -$1.14B | $15.00M | -$42.00M | $169.00M | -$2.00M | -$1.53B | $36.00M | $66.00M | -$730.00M | $695.00M |
Frequently Asked Questions About BIPH
What is Safeplus International Holdings' annual revenue?
Safeplus International Holdings reported revenue of $23.10B for the fiscal year ended Feb 28, 2026.
How fast is Safeplus International Holdings' revenue growing?
Revenue was up 9.8% for the fiscal year ended Feb 28, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 17.0%.
Is Safeplus International Holdings profitable?
Yes. Safeplus International Holdings reported net income of $449.00M for the fiscal year ended Feb 28, 2026, with a net margin of 1.9%.
How much free cash flow does BIPH generate?
For the fiscal year ended Feb 28, 2026, operating cash flow of $5.97B minus capital expenditures of $5.70B produced free cash flow of $268.00M.
How much debt does Safeplus International Holdings have?
The balance sheet dated Feb 28, 2026 reported short-term debt of $7.36B and cash and equivalents of $2.06B.
BIPH pages: Overview, Dividends, Financials